ΔΙΕΡΕΥΝΗΣΗ ΤΟΥ ΡΟΛΟΥ ΤΟΥ ΕΙΔΙΚΟΥ ΠΡΟΣΤΑΤΙΚΟΥ ΑΝΤΙΓΟΝΟΥ (PSA) ΣΤΗΝ ΠΑΘΟΛΟΓΙΑ ΤΟΥ ΠΡΟΣΤΑΤΗ

WE MEASURED SERUM PROSTATE SPECIFIC ANTIGEN (PSA) FROM 135 MEN (55 PROSTATE CANCER, 39 BENIGN PROSTATE HYPERTROPHY, 9 PROSTATITIS, 32 NORMAL). PSA IS A SPECIFIC-CELL TYPE ANTIGEN OF PROSTATE AND IS MORE SENSITIVE MARKER THAN PROSTATE ACID PHOSPHATASE (PAP)-71% TO 27,3%. PSA CAN NOT SOLVE THE PROBLEM OF PRIMARY DIAGNOSIS OF PROSTATE CANCER BUT IS AN EXCELLENT MARKER TO MONITOR THE EFFECTIVENESS OF THE TREATMENT, IT CAN PREDICT THE PROGRESSION OF PROSTATIC CARCINOMA AND REVEAL ANY CHANGE OF ITS STAGE. IT HAS THE UNIQUE USEFULLNESS OF DETECTING METASTATIC CANCER OF OTHERWISE UNKNOWN ORIGIN AND EARLY ITS ELEVATIONS FOLLOWING TOTAL PROSTATECTOMY OWING TO RECURRENT TUMOR WITH METASTASES. PSA MIGHT BE AS THEMARKER OF CHOICE TO MONITOR THERAPY FOR PROSTATIC CARCINOMA.

Grantor dc:publisher

University of Patras

Year dc:date

1988

Author dc:creator

• Περιμένης, Πέτρος

• Ειδικό προστατικό αντιγόνο
• ΚΑΡΚΙΔΙΚΟΣ ΔΕΙΚΤΗΣ
• Καρκίνος προστάτη
• Prostate cancer
• Prostate specific antigen (PSA)
• Tumor markers
• Ιατρική και Επιστήμες Υγείας
• Κλινική Ιατρική
• Medical and Health Sciences
• Clinical Medicine

Language dc:language

gre

Identifier

10.12681/eadd/0686

OAI identifier oai:identifier

oai:10442/0686